Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clomiphene citrate added to progestin-primed ovarian stimulation in women with polycystic ovarian syndrome undergoing IVF
ChiCTR-IPR-17012964Phase 4Recruiting
- Sponsor
- Shanghai Ninth People's Hospital
- Start
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of clomiphene, dydrogesterone and human menopausal gonadotrophin in female infertility and polycystic ovary syndrome (PCOS) (2 arms), sponsored by Shanghai Ninth People's Hospital. Primary endpoints: Number of oocytes retrieved, LH value and 2 more. Started Nov 2017; status: recruiting.
02
Drugs
clomiphenedydrogesteronehuman menopausal gonadotrophin
03
Conditions
female infertilitypolycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on ChiCTR-IPR-17012964.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17012964.